Hedge Fund - Opaleye Management

Ocular Therapeutix Inc (OCUL) 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2024 - Q4 (2024-12-31) $37,084,950 6.48% 4,342,500 $9.76
2 2024 - Q3 (2024-09-30) $43,717,500 7.29% 5,025,000 $8.24
3 2024 - Q2 (2024-06-30) $36,303,300 8.29% 5,307,500 $6.17
4 2024 - Q1 (2024-03-31) $60,543,556 13.19% 6,653,138 $7.10
5 2023 - Q4 (2023-12-31) $27,072,200 7.19% 6,070,000 $2.96
6 2023 - Q3 (2023-09-30) $20,309,520 6.6% 6,468,000 $4.09
7 2023 - Q2 (2023-06-30) $29,824,800 7.13% 5,780,000 $5.95
8 2023 - Q1 (2023-03-31) $32,178,093 9.63% 6,105,900 $4.75
9 2022 - Q4 (2022-12-31) $17,070,750 5.93% 6,075,000 $3.31
10 2022 - Q3 (2022-09-30) $26,830,000 11.08% 6,465,000 $5.04
11 2022 - Q2 (2022-06-30) $24,019,000 10.82% 5,974,800 $3.78
12 2022 - Q1 (2022-03-31) $29,575,000 9.18% 5,974,800 $5.54
13 2021 - Q4 (2021-12-31) $41,644,000 8.83% 5,974,800 $7.77
14 2021 - Q3 (2021-09-30) $64,800,000 12.1% 6,480,000 $11.23
15 2021 - Q2 (2021-06-30) $91,886,000 15.26% 6,480,000 $15.20
16 2021 - Q1 (2021-03-31) $106,337,000 15.61% 6,480,000 $19.26
17 2020 - Q4 (2020-12-31) $134,758,000 17.6% 6,510,000 $14.85
18 2020 - Q3 (2020-09-30) $45,540,000 8.9% 5,984,200 $8.30
19 2020 - Q2 (2020-06-30) $49,848,000 10.06% 5,984,200 $6.63
20 2020 - Q1 (2020-03-31) $25,356,000 6.71% 5,122,500 $4.94
21 2019 - Q4 (2019-12-31) $20,175,000 3.95% 5,107,500 $3.48
22 2019 - Q3 (2019-09-30) $8,436,000 3.05% 2,775,000 $4.47
23 2019 - Q2 (2019-06-30) $12,980,000 3.95% 2,950,000 $3.70
24 2019 - Q1 (2019-03-31) $7,543,000 2.08% 1,900,000 $4.02
25 2018 - Q4 (2018-12-31) $0 0% 0 $5.51
26 2018 - Q3 (2018-09-30) $5,504,000 1.4% 800,000 $6.28
27 2018 - Q2 (2018-06-30) $7,499,000 1.94% 1,111,000 $6.87
28 2017 - Q2 (2017-06-30) $0 0% 0 $9.68
29 2017 - Q1 (2017-03-31) $5,104,000 2.54% 550,000 $8.33
30 2016 - Q4 (2016-12-31) $783,000 0.46% 93,600 $7.76
31 2016 - Q3 (2016-09-30) $0 0% 0 $6.10
32 2016 - Q2 (2016-06-30) $1,287,000 0.85% 260,000 $9.91

The displayed share prices are average quarterly stock market prices.